Decreased risk of subsequent primary noncutaneous malignancies among patients with primary cutaneous malignant melanoma

Richard Wagner, J. R. Pellegrini, E. Delzell

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

It is established in the clinical literature that patients who develop specific types of malignancies are at an increased statistical risk for the development of a second primary malignancy. Previous studies have supported the theory that patients who develop primary cutaneous malignant melanoma (PCMM) have a greater risk for the development of a secondary primary noncutaneous malignancy (SPNM). Taken from the tumor registry of a community hospital, data for 504 consecutive patients (254 men and 250 women) with a diagnosis of PCMM were evaluated for the incidence of subsequent SPNM by comparing this series of patients to the general population of Connecticut. It was demonstrated that patients with PCMM had a significantly reduced incidence of SPNM (p = 0.002). Consideration should be given to possible biological and behavioral mechanisms which could explain the observed deficit.

Original languageEnglish (US)
Pages (from-to)1097-1102
Number of pages6
JournalJournal of Dermatologic Surgery and Oncology
Volume11
Issue number11
StatePublished - 1985
Externally publishedYes

Fingerprint

Neoplasms
Second Primary Neoplasms
Incidence
Community Hospital
Registries
Cutaneous Malignant Melanoma
Population

ASJC Scopus subject areas

  • Dermatology
  • Oncology

Cite this

Decreased risk of subsequent primary noncutaneous malignancies among patients with primary cutaneous malignant melanoma. / Wagner, Richard; Pellegrini, J. R.; Delzell, E.

In: Journal of Dermatologic Surgery and Oncology, Vol. 11, No. 11, 1985, p. 1097-1102.

Research output: Contribution to journalArticle

@article{23b6fc2689b84e62ad26866a756a278a,
title = "Decreased risk of subsequent primary noncutaneous malignancies among patients with primary cutaneous malignant melanoma",
abstract = "It is established in the clinical literature that patients who develop specific types of malignancies are at an increased statistical risk for the development of a second primary malignancy. Previous studies have supported the theory that patients who develop primary cutaneous malignant melanoma (PCMM) have a greater risk for the development of a secondary primary noncutaneous malignancy (SPNM). Taken from the tumor registry of a community hospital, data for 504 consecutive patients (254 men and 250 women) with a diagnosis of PCMM were evaluated for the incidence of subsequent SPNM by comparing this series of patients to the general population of Connecticut. It was demonstrated that patients with PCMM had a significantly reduced incidence of SPNM (p = 0.002). Consideration should be given to possible biological and behavioral mechanisms which could explain the observed deficit.",
author = "Richard Wagner and Pellegrini, {J. R.} and E. Delzell",
year = "1985",
language = "English (US)",
volume = "11",
pages = "1097--1102",
journal = "Dermatologic Surgery",
issn = "1076-0512",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Decreased risk of subsequent primary noncutaneous malignancies among patients with primary cutaneous malignant melanoma

AU - Wagner, Richard

AU - Pellegrini, J. R.

AU - Delzell, E.

PY - 1985

Y1 - 1985

N2 - It is established in the clinical literature that patients who develop specific types of malignancies are at an increased statistical risk for the development of a second primary malignancy. Previous studies have supported the theory that patients who develop primary cutaneous malignant melanoma (PCMM) have a greater risk for the development of a secondary primary noncutaneous malignancy (SPNM). Taken from the tumor registry of a community hospital, data for 504 consecutive patients (254 men and 250 women) with a diagnosis of PCMM were evaluated for the incidence of subsequent SPNM by comparing this series of patients to the general population of Connecticut. It was demonstrated that patients with PCMM had a significantly reduced incidence of SPNM (p = 0.002). Consideration should be given to possible biological and behavioral mechanisms which could explain the observed deficit.

AB - It is established in the clinical literature that patients who develop specific types of malignancies are at an increased statistical risk for the development of a second primary malignancy. Previous studies have supported the theory that patients who develop primary cutaneous malignant melanoma (PCMM) have a greater risk for the development of a secondary primary noncutaneous malignancy (SPNM). Taken from the tumor registry of a community hospital, data for 504 consecutive patients (254 men and 250 women) with a diagnosis of PCMM were evaluated for the incidence of subsequent SPNM by comparing this series of patients to the general population of Connecticut. It was demonstrated that patients with PCMM had a significantly reduced incidence of SPNM (p = 0.002). Consideration should be given to possible biological and behavioral mechanisms which could explain the observed deficit.

UR - http://www.scopus.com/inward/record.url?scp=0022405650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022405650&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 1097

EP - 1102

JO - Dermatologic Surgery

JF - Dermatologic Surgery

SN - 1076-0512

IS - 11

ER -